1、PwC Life SciencesIndustry in FocusFuture50October 20232Life Sciences-Future50This insight is brought to you using the capability of PwCs Life Sciences industry experts across Deals,Audit,Consulting,Risk and Tax.PwCs global network of pharmaceutical,biotech,medtech and healthcare experts works with y

2、ou to define and deliver effective solutions to the complex challenges affecting your business in all areas from innovation to regulation and patient engagement.We help our clients develop future focused business strategies and to implement the time critical programmes and procedures essential to su

3、ccess within worldwide regulatory frameworks.Our multi-disciplinary teams and global reach mean we are well placed to provide wide-ranging support wherever you need it,at home and abroad,whatever the size of your organisation.Contents3Life Sciences-Future50Foreword 4About 6Key context 7Economic cont

4、ribution 15Methodology 17UK 2023 Life Sciences Future50 20Company profiles 26Appendices 77Team overview 80Contacts 814Life Sciences-Future50As the UK sets its sights on an ambition to be a Life Sciences Superpower,harnessing the talent and capabilities from across the UKs ecosystem has never been mo

5、re critical.The UK and its academic powerhouses have created an environment where scientists are able to push the boundaries of research to create breakthrough science in areas such as biopharmaceuticals,artificial intelligence,digital health,diagnostics and devices.At the forefront of this vision f

6、or the UK is how we can enable new companies to form and set them on a path to late stage development and commercialisation.I am delighted to celebrate and showcase,in the Future50 Life Sciences report,some of the most innovative and groundbreaking companies operating in the UK life sciences sector